[ad_1] UBS analysts shook up their ratings of European drugmakers, including making a double-downgrade of…
AstraZeneca PLC
-
-
[ad_1] Ionis Pharmaceuticals IONS, +1.61% and AstraZeneca’s AZN, +0.79% Wainua has been approved by the…
-
[ad_1] AstraZeneca PLC said Tuesday it was disappointed with the outcome of the U.S. Food…
-
STOCK MARKET
How a nasal vaccine could reduce the risk of COVID infections — and new variants
by userby user[ad_1] For many, one of the defining moments of the COVID-19 pandemic was when they…
-
[ad_1] AstraZeneca PLC on Monday said its cancer drug Enhertu has shown clinically meaningful and…
-
[ad_1] AstraZeneca PLC said Tuesday that Forxiga has been approved in the European Union for…
-
STOCK MARKET
Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns
by userby user[ad_1] Drug companies planning to raise prices on cancer drugs and other life-saving treatments are…
-
STOCK MARKET
European drugmakers including AstraZeneca pony up for U.S.-listed biopharmas
by userby user[ad_1] European drugmakers on Monday announced a trio of deals around a billion dollars each…
-
STOCK MARKET
AstraZeneca’s Forxiga gets EU approval recommendation for symptomatic chronic heart failure
by userby user[ad_1] AstraZeneca PLC said Monday that its Forxiga drug has been recommended for approval in…
-
[ad_1] AstraZeneca PLC said Monday that its Imfinzi and Imjudo combinations have been recommended for…
- 1
- 2